{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:18:32Z","timestamp":1793089112703,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.pedneo.2015.09.010","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T08:31:10Z","timestamp":1450859470000},"page":"396-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential Effects of Interleukins on the Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"57","author":[{"given":"Ling-Yun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Fang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2015.09.010_bib1","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1007\/s00296-011-2249-4","article-title":"Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"32","author":"Hedrich","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.pedneo.2015.09.010_bib2","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1542\/peds.2004-2190","article-title":"Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis","volume":"116","author":"Binstadt","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2015.09.010_bib3","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1542\/pir.27-4-e24","article-title":"Juvenile idiopathic arthritis: a review for the pediatrician","volume":"27","author":"Goldmuntz","year":"2006","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.pedneo.2015.09.010_bib4","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1084\/jem.20070070","article-title":"Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade","volume":"204","author":"Allantaz","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.pedneo.2015.09.010_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/pbc.21019","article-title":"Etanercept for therapy-resistant macrophage activation syndrome","volume":"50","author":"Makay","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pedneo.2015.09.010_bib6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.pedneo.2015.09.010_bib7","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.4049\/jimmunol.0903271","article-title":"IL-17 contributes to angiogenesis in rheumatoid arthritis","volume":"184","author":"Pickens","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib8","first-page":"912","article-title":"IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA)","volume":"28","author":"M\u00f6ller","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/rheumatology\/34.5.454","article-title":"Inflammatory cytokine responses in juvenile chronic arthritis","volume":"34","author":"Rooney","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/art.20198","article-title":"Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?","volume":"50","author":"Grom","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pedneo.2015.09.010_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pedneo.2015.09.010_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature05970","article-title":"IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells","volume":"448","author":"Korn","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.pedneo.2015.09.010_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","article-title":"Clinical value of blocking IL-6 receptor","volume":"21","author":"Mima","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib14","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in\u00a0vitro IL-17 production via cyclosporin A-sensitive mechanism","volume":"164","author":"Ziolkowska","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1006\/cyto.2000.0681","article-title":"Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis","volume":"12","author":"Chabaud","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.pedneo.2015.09.010_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1084\/jem.20040590","article-title":"Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite","volume":"200","author":"Min","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.pedneo.2015.09.010_bib17","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: Regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib18","first-page":"390","article-title":"International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: Second Revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/art.1780290216","article-title":"A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis","volume":"29","author":"Cassidy","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pedneo.2015.09.010_bib20","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.pedneo.2015.09.010_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3959(83)90126-4","article-title":"The validation of visual analogue scales as ratio scale measures for chronic and experimental pain","volume":"17","author":"Price","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.pedneo.2015.09.010_bib22","first-page":"40","article-title":"Value of disease activity score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis","volume":"31","author":"Balsa","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib23","first-page":"S93","article-title":"The disease activity score and the EULAR response criteria","volume":"23","author":"Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib24","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1182\/blood-2008-05-155846","article-title":"Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti\u2013IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease","volume":"112","author":"Nishimoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pedneo.2015.09.010_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pedneo.2015.09.010_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0092-8674(94)90235-6","article-title":"Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway","volume":"77","author":"Akira","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.pedneo.2015.09.010_bib28","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/j.1460-2075.1990.tb08316.x","article-title":"A nuclear factor for IL-6 expression (NF-IL6) is a member of C\/EBP family","volume":"9","author":"Akira","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.pedneo.2015.09.010_bib29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00002281-200309000-00010","article-title":"Interleukin 6 as a therapeutic target in systemic-onset juvenile idiopathic arthritis","volume":"15","author":"Yokota","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib30","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1248\/bpb.30.2001","article-title":"Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases","volume":"30","author":"Ohsugi","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.pedneo.2015.09.010_bib31","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar1038","article-title":"IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB-and Pi3-kinase\/Akt-dependent pathways","volume":"6","author":"Hwang","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.pedneo.2015.09.010_bib32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.intimp.2014.02.038","article-title":"Tgf-\u03b2\/Smad signaling pathway regulates Th17\/Treg balance during echinococcus multilocularis infection","volume":"20","author":"Pang","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.38896","article-title":"Combined inhibition of tumor necrosis factor \u03b1 and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody","volume":"67","author":"Fischer","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3892\/mmr.2014.2170","article-title":"Th17 cells are associated with the Th1\/Th2-cell balance during echinococcus multilocularis infection","volume":"10","author":"Ma","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.pedneo.2015.09.010_bib35","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20072057","article-title":"Development and characterization of IL-21\u2013producing CD4+ T cells","volume":"205","author":"Suto","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.pedneo.2015.09.010_bib36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/icb.2012.17","article-title":"IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells","volume":"90","author":"Diehl","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.pedneo.2015.09.010_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7150\/ijbs.5996","article-title":"Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis","volume":"9","author":"Carbone","year":"2013","journal-title":"Int J Biol Sci"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957215001850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957215001850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T22:00:07Z","timestamp":1567461607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957215001850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1875957215001850"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2015.09.010","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Effects of Interleukins on the Pathogenesis of Systemic Onset Juvenile Idiopathic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2015.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}